It was early 2023. In a ground-floor laboratory at the National Centre for Biological Sciences (NCBS) in north Bengaluru, Ph.D candidate Nayan Chakraborty was readying to examine the results of another iteration of an experiment he had been attempting for three months. There was no reason to believe this trial, nearly his 1,000th, would be...
